Slotkin's Bill to Lower Prescription Drug Costs Passes House With Broad Bipartisan Support
October 29, 2019
October 29, 2019
WASHINGTON, Oct. 29 -- Rep. Elissa Slotkin, D-Michigan, issued the following news release:
* * *
- Real-Time Benefits Act would ensure patients are offered the lowest-cost drug available, encourages competition to bring costs down across the board
* * *
U.S. Rep. Elissa Slotkin's (MI-08) bipartisan Real-Time Benefits Act passed the U.S. House of Representatives today with broad bipartisan support, representing an important achievement on S . . .
* * *
- Real-Time Benefits Act would ensure patients are offered the lowest-cost drug available, encourages competition to bring costs down across the board
* * *
U.S. Rep. Elissa Slotkin's (MI-08) bipartisan Real-Time Benefits Act passed the U.S. House of Representatives today with broad bipartisan support, representing an important achievement on S . . .